In 2023, Federico Grossi, M.D., Ph.D. earned $1.44M in total compensation at Apellis Pharmaceuticals, Inc., including $741.00K salary and $694.69K bonus. Most recently sold 2,500 shares in Jan 2023. Currently holds stock worth $1.93M.
Compensation History
Annual executive compensation data for Federico Grossi, M.D., Ph.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.44M
Salary
$741.00K
Bonus
$694.69K
Other
$7.13K
Salary
$741.00KBoard Justification
The compensation program is designed to attract, motivate, and retain executives, aligning their interests with those of stockholders through a pay-for-performance philosophy.
Bonus
$694.69KBoard Justification
Annual cash incentive program based on company performance metrics, resulting in a payout of 125% of target.
Other Compensation
$7.13KBoard Justification
Other compensation includes life insurance premiums and contributions to the 401(k) plan.
Restricted Stock
Board Justification
No stock vested in 2023 as the focus is on cash compensation and performance-based bonuses.
Performance Metrics
Performance metrics for 2023 included attainment of net product revenues for EMPAVELI and SYFOVRE, achievement of regulatory objectives, and progress of clinical trials.
Federico Grossi, M.D., Ph.D.
Ex-CEO of Apellis Pharmaceuticals, Inc.
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
CEO of Apellis Pharmaceuticals, Inc. for
Until January 2023
Previous Experience
Chief Medical Officer at Apellis Pharmaceuticals, Inc.
Holdings
Track Federico Grossi, M.D., Ph.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$2.24M
$2.24M
45,956 APLS shares
What if they kept their stock?
If Federico Grossi, M.D., Ph.D. didn't sell their stock, today they would have:
Extra APLS45,956 shares worth $934.29K.
This is -58.22% and $1.30M less than what they got when they sold the stock.
Insider Trading
Federico Grossi, M.D., Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.
$121.98K
APLS at $48.79/share
Jan 5, 2023
Sale
$124.83K
APLS at $49.93/share
Dec 1, 2022
Sale
$152.08K
APLS at $60.83/share
Nov 1, 2022
Sale
$166.73K
APLS at $66.69/share
Oct 3, 2022
Sale
$150.75K
APLS at $60.30/share
Sep 1, 2022
Sale
$139.98K
APLS at $55.99/share
Aug 1, 2022
Sale
$104.45K
APLS at $41.78/share
Jun 1, 2022
Sale
$108.90K
APLS at $43.56/share
Apr 21, 2022
Sale
$14.84K
APLS at $39.57/share
Mar 15, 2022
Sale
$16.32K
APLS at $43.53/share
Mar 1, 2022
Sale
Rivals
Compare Federico Grossi, M.D., Ph.D. with competitor CEOs and industry peers.